Progastrin, Annexin A2 and Tumor-Associated Macrophages in Gastric Adenocarcinomas

IntroductionThis study investigates the immunohistochemical expression of hPG, ANXA2, and the polarization of tumor-associated macrophages (TAMs) in gastric adenocarcinomas. Methods: A retrospective analysis was conducted on FFPE tissue samples from 60 patients with gastric adenocarcinoma (primary tumors, lymph node metastases and normal-looking gastric mucosa), and on gastric biopsies from 23 healthy controls. The expression of hPG and ANXA2 was quantified using the H-score, and the CD163/HLA-DR ratio was used to infer macrophage polarization (M2/M1). Results: ANXA2 expression was significantly elevated in primary tumors and lymph node metastases compared to normal and healthy controls and increased with tumor grade. High ANXA2 expression was associated with poorer overall and disease-free survival. In contrast, hPG expression, although positively correlating to ANXA2 expression, showed no prognostic value. The M2/M1 ratio increased with tumor progression, showed a negative correlation with ANXA2 expression and failed to correlate significantly with survival. Conclusions: This study is the first to demonstrate the adverse prognostic impact of ANXA2 overexpression in gastric adenocarcinoma tissues from Caucasian patients, hinting to its potential utility as a prognostic biomarker and therapeutic target. Further large-scale studies could aid validate these findings and explore the therapeutic potential of targeting ANXA2 and modulating the TAM polarization.